NBSE
NeuBase Therapeutics, Inc. Common Stock
NBSE
NBSE
Delisted
NBSE was delisted on the 10th of May, 2024.
38 hedge funds and large institutions have $3.34M invested in NeuBase Therapeutics, Inc. Common Stock in 2017 Q3 according to their latest regulatory filings, with 5 funds opening new positions, 8 increasing their positions, 6 reducing their positions, and 3 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
100% less call options, than puts
Call options by funds: $0 | Put options by funds: $2K
Holders
38
Holding in Top 10
–
Calls
–
Puts
$2K
Top Buyers
| 1 | +$311K | |
| 2 | +$296K | |
| 3 | +$227K | |
| 4 |
Renaissance Technologies
New York
|
+$148K |
| 5 |
VF
Virtu Financial
New York
|
+$24K |
Top Sellers
| 1 | -$383K | |
| 2 | -$45K | |
| 3 | -$39K | |
| 4 |
Millennium Management
New York
|
-$11K |
| 5 |
CCB
Cutter & Co Brokerage
Ballwin,
Missouri
|
-$4.33K |